|
| |
CarringtonWith more than $70 million in basic and clinical research, Carrington Laboratories has accomplished the centuries-old goal of producing proven, quality products from the inner-leaf gel of the Aloe Vera plant. Carrington's scientific, patented process guarantees that specific measured amounts of Aloe Vera can be found in every Carrington product.
Carrington grows its Aloe Vera on the company's plantation in Costa Rica, ensuring an organic environment of fresh sunshine, warm temperatures, and volcanic soil. The Aloe Vera is harvested and freeze dried using a patented process and then shipped to the company's modern manufacturing facility in Texas.
Carrington formulates the aloe raw materials into a variety of FDA or USDA regulated devices, biologics, drugs in development, adjuvants, and various cosmetic and food grade products.
Through Carrington's wholly owned subsidiary, Caraloe Inc., the company produces nutraceutical raw materials. Carrington's consumer products division, AloeCeuticals®, was launched in July 1999. AloeCeuticals® are the only Aloe Vera based products on the market that contain stabilized and standardized concentrations of complex carbohydrates and carry DSHEA claims that they enhance or promote the body's immune function. Carrington Laboratories, Harvesting The Power of Nature™.
| Contact Details: |
| 2001 Walnut Hill Lane |
| Irving |
| TX |
| 75038 |
| United States of America |
| Tel: | (972) 518-1300 |
| Fax: | (972) 518-1020 |
| Email: | meaton@carringtonlabs.com |
| WWW: | www.carringtonlabs.com/
|
|
Loading...
|
Recent Publications by Carrington: |  |
Are there theory of mind regions in the brain? A review of the neuroimaging literature.
There have been many functional imaging studies of the brain basis of... | 29th September, 2009
| Department of Psychiatry, The University of Oxford, Warneford Hospital,
| Hum Brain Mapp. 2009 Aug;30(8):2313-35.
DOI Direct Link |
Cardiogenic arterial thromboembolism causing non-ambulatory tetraparesis in a cat.
A 1-year-old oriental cat was presented with a peracute onset of... | 21st August, 2009
| Veterinary Specialist Group, UNITEC, 97 Carrington Road, Mount Albert,
| J Feline Med Surg. 2009 Aug 17.
DOI Direct Link |
Sex-specific defence behaviour against brood parasitism in a host with female-only incubation.
Nest protection against intruders is an indispensable component of avian... | 14th August, 2009
| Institute of Vertebrate Biology, Academy of Sciences of the Czech
| Behav Processes. 2009 May;81(1):34-8. Epub 2008 Dec 30.
DOI Direct Link |
Adherence to walking or stretching, and risk of preeclampsia in sedentary pregnant women.
Pregnant women at risk for preeclampsia may benefit from the positive... | 12th August, 2009
| School of Nursing, University of North Carolina at Chapel Hill, 5008
| Res Nurs Health. 2009 Aug;32(4):379-90.
DOI Direct Link |
The popcorn Wolbachia infection of Drosophila melanogaster: can selection alter Wolbachia longevity effects?
Wolbachia popcorn (wMelPop), a life-shortening strain of Wolbachia, has... | 9th June, 2009
| Centre for Environmental Stress and Adaptation Research, Department of
| Evolution. 2009 Oct;63(10):2648-57. Epub 2009 Jun 4.
DOI Direct Link |
→View more Carrington research publications. |
Press Releases on Carrington:
|
 |
| Sinovac Files Shelf Registration Statement |
18th November, 2009 |
Sinovac Biotech Ltd. |
BEIJING, Nov. 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA),
a leading developer and provider of vaccines, announced today that it has
filed a shelf registration statement on Form F-3
|
| Sinovac's PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric Population |
17th November, 2009 |
Sinovac Biotech Ltd. |
BEIJING, Nov. 17 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA),
a leading developer and provider of vaccines in China, announced today that it
received a revised production license from
|
| Sinovac Reports Unaudited Third Quarter 2009 Financial Results |
15th November, 2009 |
Sinovac Biotech Co., Ltd. |
-- Cash and cash equivalents at September 30, 2009 was $46.6 million.
Business Highlights
-- In August, Sinovac reported positive top-line results from the completed
clinical
|
| Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook |
10th November, 2009 |
Reportlinker |
-- Profiles of key emerging drug delivery technologies and profiles of
leading companies, by type of technology
Who Should Buy This Report:
-- Companies interested in understanding
|
| Sinovac to Host Conference Call to Report 2009 Third Quarter Financial Results |
10th November, 2009 |
Sinovac Biotech Ltd. |
BEIJING, Nov. 10 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
(NYSE Amex: SVA), a leading provider of vaccines in China, today announced
that it will host a conference call on Monday, November 16,
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 20 individuals from Carrington using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 660 times since April 2007, the link to the organisation's website has been followed 128 times Recent Search Terms used to find this page: Carrington Laboratories 1997 | Aloe vera investigations carrington | aloeceuticals labs tx | carrington pharmaceut | aloe vera and carrington | carrington labs april 2 2009 | . Search for more companies in Irving Search for more companies in TX This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Carrington |
